Repeated need for rapid tranquillisation ‐ more than 1 injection · patients with psychosis‐induced aggression or agitation
It is very uncertain whether HALOPERIDOL changes repeated need for rapid tranquillisation ‐ more that 1 injection compared with OTHER ANTIPSYCHOTIC: b. CHLORPROMAZINE (very low certainty).
1 finding from 1 review
Repeated need for tranquillisation ‐ needing additional injections during 24 hours · patients with psychosis‐induced aggression or agitation
HALOPERIDOL may leads to lower repeated need for tranquillisation needing additional injection… compared with PLACEBO/NIL (low certainty).
1 finding from 1 review
Repeated need for rapid tranquillisation ‐ more than 1 injection · psychosis‐induced aggression or agitation
HALOPERIDOL probably leads to higher repeated need for rapid tranquillisation ‐ more than 1 injection compared with OTHER ANTIPSYCHOTIC: c. DROPERIDOL (moderate certainty).
1 finding from 1 review
Repeated need for rapid tranquillisation ‐ more than 3 injections · patients with psychosis‐induced aggression or agitation
It is very uncertain whether HALOPERIDOL changes repeated need for rapid tranquillisation ‐ more than 3 injections compared with OTHER ANTIPSYCHOTIC: k. ZUCLOPENTHIXOL ACETATE (very low certainty).
1 finding from 1 review
Repeated need for rapid tranquillisation ‐ needing additional injection · patients with psychosis‐induced aggression or agitation
HALOPERIDOL may leads to lower repeated need for rapid tranquillisation ‐ needing additional… compared with OTHER ANTIPSYCHOTIC: a. ARIPIPRAZOLE (low certainty).
1 finding from 1 review
Repeated need for rapid tranquillisation ‐ more than 1 injection · patients with psychosis‐induced aggression or agitation
It is very uncertain whether HALOPERIDOL changes repeated need for rapid tranquillisation more than 1 injection compared with BENZODIAZEPINE: b. LORAZEPAM (very low certainty).
1 finding from 1 review
Intervention not reported
PIPP score during post‐injection period Range of scale 0‐21 for infants < 28 weeks PMA and 0‐18 for infants > 36 weeks PMA A lower score = less pain (Stevens 1996; Stevens 2014a) · neonates with pain associated with venipuncture
1 finding from 1 review
Intervention not reported
DAN score during the post‐injection period Range of scale 0‐10 A lower score = less pain (Carbajal 1997) · neonates with pain associated with venipuncture
1 finding from 1 review
All pain scores during injection Due to range of pain scores used, data analysed using SMDs. Pain scores were measured during and up to 3 minutes following completion of vaccination. · Infants 1 to 12 months during vaccination
2 findings from 1 review
Heart rate · Infants 1 to 12 months during vaccination
1 finding from 1 review
Injection site reactions ‐ induration ‐ swelling · patients with local and systemic reactions
Local and systemic reactions after administration of Tetanus… showed no clear difference in injection site reactions ‐ induration ‐ swelling compared with saline placebo (moderate certainty).
1 finding from 1 review
Injection site pain · patients with local and systemic reactions
Local and systemic reactions after administration of Tetanus… probably leads to higher injection site reactions ‐ pain at injection site compared with saline placebo (moderate certainty).
1 finding from 1 review
Injection site reactions ‐ erythema ‐ redness · patients with local and systemic reactions
Local and systemic reactions after administration of Tetanus… showed no clear difference in injection site reactions ‐ erythema ‐ redness compared with saline placebo (moderate certainty).
1 finding from 1 review
Need for additional injection Number of additional injections · patients undergoing cataract surgery
Peribulbar showed no clear difference in need for additional injection Number of additional injections compared with retrobulbar (low certainty).
1 finding from 1 review
Adverse effects: pain on injection (solution deposition), Heft-Parker VAS 0-170 mm · emergency department procedural sedation
1 finding from 1 review
Intravenous injection of tranexamic acid · women with uterine fibroids
Interventions to reduce blood loss during myomectomy for fibroids showed no clear difference in intravenous injection of tranexamic acid compared with placebo or no treatment (low certainty).
1 finding from 1 review
Intervention not reported
Mean time from injection to placenta removal Mean time from injection to placenta removal. · women with retained placenta
1 finding from 1 review
Intervention not reported
Maternal pain between injection and discharge from labour ward Maternal pain between injection and discharge from labour ward · women with retained placenta
It is very uncertain whether the intervention changes maternal pain between injection and discharge from labour ward… (very low certainty).
1 finding from 1 review
Intervention not reported
Nausea between injection and discharge from labour ward Nausea between injection and discharge from labour ward · women with retained placenta
It is very uncertain whether the intervention changes nausea between injection and discharge from labour ward Nausea… (very low certainty).
1 finding from 1 review
Number of patients died of cardiac failure ‐ Astragaloside injection versus support therapy · patients with viral myocarditis
It is very uncertain whether herbal medicines changes number of patients died of cardiac failure: Astragaloside injection… compared with supportive therapy (very low certainty).
1 finding from 1 review